EMA Explores Optimizing Vaccine Development In Immunocompromised Patients

 
• By Vibha Sharma
Senior woman receives a vaccination
Premarket clinical trials for new vaccines do not usually include immunocompromised individuals • Source: Shutterstock

More from Europe

More from Geography